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The objective of this study was to study associations of a wide range of halogenated               
biphenyls, dibenzo-p-dioxins, dibenzofurans, and diphenylethers with body mass index         
(BMI) and evaluate changes in their concentration following bariatric surgery​. 
Methods 
Subcutaneous fat, visceral fat, and liver tissue samples were collected from 106 patients             
undergoing Roux-en-Y gastric bypass surgery for weight loss or patients who were            
undergoing abdominal surgery for non-bariatric reasons. We measured concentrations of an           
extensive panel of chlorinated and brominated biphenyls, dioxins, and furans, and brominated            
diphenylethers in the samples. We conducted linear regression to examine associations with            
BMI, adjusting for age and gender. Changes in concentration for indicator chemicals were             
evaluated in samples collected following bariatric surgery in a small sub-population.  
Results 
After adjustments for age and gender and correction for multiple testing seven            
ortho-chlorinated biphenyls, one non-ortho-chlorinated biphenyl, four PCDD/F’s and one         
ortho-brominated biphenyl were associated with BMI. The strongest associations between          
BMI and lipid-adjusted concentrations were seen with PCB-105 in subcutaneous fat           
(beta=16.838 P-val=1.45E-06) PCB-126 in visceral fat (beta=15.067 P-val=7.72E-06) and         
PCB-118 (beta=14.101 P-val=2.66E-05) in liver. The concentrations of sum PCBs,          
chlorinated TEQ's and brominated compounds increased significantly with weight loss in           
subcutaneous fat in a group of ten individuals resampled up to five years after bariatric               




We show that selected polychlorinated biphenyls PCBs and structurally related          
polychlorinated dibenzo-p-dioxins dibenzofurans (PCDD/Fs) were associated with BMI.        






Halogenated biphenyls, dibenzo-p-dioxins, dibenzofurans, and diphenylethers are chemicals        
that can interfere with endocrine systems and are implicated in the pathogenesis of obesity,              
cancer, birth defects, and other developmental disorders(1-5). There are increasing concerns           
that some of these chemicals can interfere with regulatory processes involved in lipid             
metabolism and in the control of adipocyte function resulting in excess weight and obesity(6,              
7). While some of these chemicals are of natural origin, the majority are synthetic chemicals,               
which have been released by human activities into the environment. Among the chemicals in              
this broad category are polychlorinated biphenyls (PCBs) and structurally related          
polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), the brominated dioxins        
(PBDDs), furans (PBDFs), and biphenyls (PBBs), diphenyl ethers (PBDEs)(8, 9). The           
patterns of distribution of these chemicals in the body have been studied in numerous              
species(10). These chemicals are highly lipophilic and tend to distribute in the body             
primarily on the basis of the lipid content of the tissue, with data indicating that in general,                 
the concentration of these compounds in lipid throughout the body is usually very similar(8).              
PCDD/Fs, PBDD/Fs, and coplanar PCBs are also found in liver tissue as they bind to a                
specific protein, cytochrome p4501a2, which is present in the liver and can be induced by               
dioxin activation of the aryl hydrocarbon receptor(11, 12). As a result, hepatic concentrations             
of these compounds can significantly exceed the concentrations expected on the basis of the              
lipid content of the liver.  
Concentrations of many of these environmental chemicals have been monitored in the blood             
in the US population through the US National Health and Nutrition Examination Survey             
(NHANES), however, to our knowledge, there have been no systematic biomonitoring           
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studies for chlorinated dioxins in UK populations and there are no UK studies looking at the                
association of environmental chemicals with BMI and obesity. Furthermore, since the           
concentrations of these compounds vary with the lipid content in the body, there are concerns               
that their concentrations might increase in the body following rapid weight lipid loss             
following procedures such as bariatric surgery(13-15). There are limited data looking at the             
changes in the body concentrations of these environmental chemicals following bariatric           
surgery and no data looking at the changes of these in liver tissue following weight loss(16,                
17). For example, Jansen A et.al.(18) analyzed 17 different polyfluoroalkylated substances           
(PFASs) to assess the effect of weight loss before and one year after bariatric surgery, and                
showed that the the plasma levels of all PFASs decreased upto 4-34%. Another study(19)              
examined 17 persistent organic pollutants (POPs) and 13 PFAA at baseline and following             
bariatric surgery and showed that there was a significant increase in POP levels in response               
obesity surgery.  
The prevalence of obesity is increasing in the western world and genetic factors explain only               
a small proportion of the heritability of BMI/obesity(20, 21). It is therefore important to              
investigate the association of known potentially endocrine active compounds with BMI. The            
objectives of this study were 1) to look at the association of selected persistent lipophilic               
environmental chemicals with BMI and 2) compare the concentration of these compounds in             
the body before and after bariatric surgery in a subset of the study population. 
Methods 
Study population and sample collection 
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The study population consisted of patients undergoing Roux-en-Y gastric bypass surgery for            
weight loss or patients who were undergoing abdominal surgery for non-bariatric reasons            
(mainly Nissen fundoplication for gastro-oesophageal reflux disease) from April 2010 until           
March 2015. Informed consent for the study was obtained and National Research Ethics             
Committee, Yorkshire and Humber – South Yorkshire, UK (REC reference 10/H1304/13),           
approved the study. Anthropometric parameters including height and weight were measured           
on the day of surgery. During surgery, tissue samples were taken including liver (500 mg)               
and adipose tissue (visceral and subcutaneous: 40 g each). Opportunistic contacts for            
follow-up sampling with the participants were also made when they attended the bariatric             
surgery follow-up clinic. For those who consented, subcutaneous fat biopsies were taken at             
follow-up. An incision was made in the anterior abdominal wall under local anaesthesia after              
sterile precaution and subcutaneous fat biopsies were taken. Samples were stored at -80ºC             
until packed in dry ice for transport to the UK National Reference Laboratory for              
Contaminants in Food and Feed (FERA) laboratory for analysis. After receipt at the FERA              
laboratory, samples were stored at -20ºC until analysis. These dioxins are considered very             
stable compounds and are highly persistent in vivo and vitro with an estimated half life of                
9-15 yrs on soil surfaces(22). 
Sample analysis 
The method (23) used for the preparation, extraction and analysis of samples is             
comprehensively validated, formally accredited and forms part of the modular CEN method            
EN16215:2012. In brief, samples were fortified with 13C-labelled analogues of target           
compounds and exhaustively extracted using mixed organic solvents. PBDEs and          
ortho-substituted PCBs/PBBs were separated from non-ortho substituted PCBs/PBBs,        
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PCDD/Fs and PBDD/Fs by fractionation on activated carbon. The two fractions were further             
purified using adsorption chromatography on alumina. Analytical measurement was carried          
out using high-resolution gas chromatography-high resolution mass spectrometry        
(HRGC-HRMS) for all analytes apart from the ortho-substituted PCBs which were analysed            
by high-resolution gas chromatography-unit resolution mass spectrometry (HRGC-LRMS).        
Lipid content was measured using a method based on BS:4401: Part 4 1970 (Werner-Schmidt              
Method).  
The analysis is accredited (UKAS) to ISO 17025 standards, with the inclusion of an in-house               
reference material and method blanks which were evaluated prior to reporting of sample data              
and used to determine the limits of detection. Further quality assurance measures included the              
successful participation in international inter-comparison exercises such as Dioxins in          
Food-2011 to 2014, and EURL-run PT exercises on dioxins, dioxin-like PCBs, ICES-6 PCBs             
and PBDEs. Additionally, quality control evaluation for the accompanying data follows the            
criteria specified for chlorinated dioxins and PCBs (Commission Regulation 252/2012,          
(European Commission, 2012). Not every targeted sample was collected, and for a variety of              
reasons, the number of analysed samples varied by matrix and chemical compound group.             
For example, in some cases, particularly for liver samples, the collected sample was of              
insufficient mass to allow analysis for all of the target chemical groups. In some cases the                
analytical results were flagged as “indicative” and were inconsistent with other data collected             
for the same compounds, and the decision was made to exclude those analytical results from               
the statistical analyses. Finally, for brominated dioxins and furans, 17 out of 21 contributing              
to toxic equivalency (TEQ) were measured due to the lack of available standards.             
Specifically, octa-brominated dioxin and furan were not measured and only one           
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hepta-brominated (a hepta-brominated furan) was measured. Although these have low toxic           
equivalency factor (TEF) values they are likely to contribute to total brominated TEQ, so it is                
likely that the brominated TEQ values will be somewhat underestimated. 
Statistical methods 
Summary statistics for each measured congener in each tissue (detection frequency,           
geometric mean, geometric standard deviation, minimum and maximum) were generated in R            
3.5.0.  
Several studies have shown a significant association of age with distribution of dioxin             
chemicals in the population. A simple bivariate correlation which will be confounded by age,              
is therefore not useful and can be misleading. Hence, we assessed the association of these               
environmental chemicals using regression analysis adjusting for both age and gender. Linear            
regression analysis implemented in R was used to test the association of BMI with the               
log10-transformed concentration of each compound, adjusted for age and gender. Bonferroni           
correction was used to identify a threshold for statistical significance (0.05/number of tests)             
to account for multiple testing. Since the environmental chemicals showed a high degree of              
correlation in subcutaneous tissues, visceral fat and liver we used a conservative Bonferroni             
correction of  0.05/63 where 63 is the number of chemicals measured across all the tissues. 
Chlorinated PCBs and PCDD/Fs were analysed in baseline and follow-up samples from 10              
participants. Sensitivity analysis was performed by 1) imputing missing data with random            
forest algorithm imputation in R and 2) by using raw values on environmental chemicals              
(rather than log-transformed). 
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To assess changes in analyte concentrations following weight loss, changes in the sum of              
three persistent indicator PCBs (138, 153, and 180) and in lower bound estimates of              
chlorinated ED were examined. Baseline and follow-up fat samples were analysed for            
selected brominated compounds in 10 individuals. BDE 153 was selected as a marker to              
examine changes in persistent brominated compound concentrations in these two participants.           
Shapiro-Wilk tests were used to compare the median concentrations of the analytes before             
and after the bariatric surgery. 
Results 
Supplementary Figure 1 shows the study flow chart. Table 1 shows the demographic             
characteristics of the study populations and the compound measured in the study. The study              
consisted of 106 participants with 64% females with a median age of 55 (IQR =44-56) years                
and a median BMI of 37 (IQR=27-37) kg/m​2​. We looked at eighty-one environmental             
chemicals consisting of twenty-one ortho-chlorinated biphenyls, four non-ortho-chlorinated        
biphenyls, seventeen PCDD/Fs, seventeen polybrominated diphenyl ethers, seven        
ortho-brominated biphenyls, 3 non-ortho-brominated biphenyls and 12 PBDD/Fs. Of the 81           
compounds, 18 were not included in subsequent analyses because detection frequencies were            
below 65% in all tissues. ​Supplementary table 1 and ​2 shows the summary statistics for the                
concentrations of each analyte in subcutaneous fat, visceral fat and liver. Concentrations of             
most of these chemicals show high correlation with each other and are also highly correlated               
in subcutaneous fat, visceral fat and liver (​Supplementary figures 1, 2, 3, 4)​. 
Figure 1 shows a heatmap of the beta coefficients for associations between BMI and              
log​10​-transformed, lipid-adjusted concentrations of 63 compounds after adjustments for age          
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and gender in subcutaneous fat, visceral fat and liver. Highly significant associations between             
BMI and compounds are indicated with darker shades of red while less significant             
associations are shown in blue. After adjustments for age and gender and correction for              
multiple testing (P<0.007, the threshold for Bonferroni correction​) ​BMI was significantly           
associated with seven ortho-chlorinated biphenyls, one non- ortho-chlorinated biphenyl, four          
PCDD/F’s and one ortho-brominated biphenyl (Table 2). The strongest associations were           
seen for PCB-105 in subcutaneous fat (beta=16.838 P-val=1.45E-06) PCB-126 in visceral fat            
(beta=15.067 P-val=7.72E-06) and PCB-118 (beta=14.101 P-val=2.66E-05) in liver. All         
associations were positive except for 2,2',4,4',5,5'-hexabromobiphenyl (BB-153)in the liver,         
which showed a negative correlation with BMI.  
Changes in the concentrations selected compounds following a bariatric surgery 
Follow-up subcutaneous fat biopsies of sufficient volume to allow analysis were collected            
from 10 bariatric surgery group participants. The biopsies were collected following an            
average of 2.8 years after initial surgery (range 1 to 4.8 years) and participants lost an average                 
of 35.3% of their pre-surgery body weight. Fat mass was estimated at the baseline surgery               
time point and at the follow-up sample time using a prediction formula based on age, gender,                
and BMI(24). Based on these estimates, the participants lost an average of 48.6% of their               
body fat (range 38.1 to 60.6%). ​Figure 2a and 2b shows the concentrations of a sum of                 
key indicator PCBs (138, 153, and 180) and chlorinated toxic equivalency (TEQ) before and              
after bariatric surgery. In the 10 follow-up participants, the mean concentration of the sum of               
indicator PCBs increased from 111.74 μg/kg lipid to 240.6 μg/kg (P=0.02) while the mean              
chlorinated TEQ concentration increased from 10.6 ng/kg lipid to 23.0 ng/kg lipid (P= 0.02).              
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BDE-153 was also measured in two participants before and after surgery and the mean              




This is the first study in the UK population looking at the association of a suite of lipophilic,                  
persistent chlorinated and brominated biphenyls, dioxins, furans, and diphenylethers with          
BMI as well as changes in their concentration following bariatric surgery and weight loss.              
We show that several ortho-chlorinated biphenyls and non-ortho-chlorinated biphenyls and          
PCDD/F’s are associated with BMI and that the concentrations of these environmental            
chemicals in fat tissues increase following bariatric surgery. 
Our study showed that BMI was positively associated with selected polychlorinated           
biphenyls PCBs and structurally related polychlorinated dibenzo-p-dioxins dibenzofurans        
(PCDD/Fs) whereas BMI was not generally associated with the brominated dioxins (PBDDs),            
furans (PBDFs), and biphenyls (PBBs), diphenyl ethers (PBDEs) after correction for multiple            
testing. The positive association between concentrations of many of these compounds and            
age has been well documented in the literature; however, studies looking at the association              
with BMI with environmental chemicals have been equivocal(25). Since the increase in BMI             
also correlates with an increase in body lipids the concentrations of environmental chemicals             
in the body can increase or decrease depending upon the time course of environmental              
exposure to these compounds, acquisition of body fat, and lipophilic properties of these             
compounds. As a result, it is difficult to establish a causal relationship between these              
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compounds and BMI. A study by Dirinck et al.(26) showed negative correlation between             
BMI, waist, fat mass percentage, total and subcutaneous abdominal adipose tissue, and serum             
levels of PCB 153, 180, 170, and the sum PCBs but positive association of              
β-hexachlorocyclohexane (βHCH) with BMI. On the other hand studies have also indicated            
that increasing body mass index (BMI) may be associated with increased serum lipid             
concentrations of dioxins (Collins et al. 2007; Flesch-Janys et al. 1996; Garabrant et al. 2009;               
Kim et al. 2011; Landi et al. 1998; Michalek et al. 1996; Ott et al. 1993, Tuomisto et al.                   
Toxicol Lett. 2016). Many of these studies have been conducted in occupationally exposed             
populations who have elevated serum concentrations of PCDD/Fs compared to the general            
population. Relatively little information is available to assess the impact of obesity on             
background chlorinated dioxin levels, and no information is available for brominated dioxins.            
With the increasing prevalence of obesity in the general population in many countries,             
evaluation of if, and how much, dioxin levels are associated with obesity becomes relevant to               
risk assessment for these compounds. There are various sources of these endocrine active             
chemicals, and according to some studies, exposure to chlorinated POPs by the general             
population continues, mostly through consumption of fatty foods of animal origin. Thus a             
high intake of animal source food can lead to higher levels of endocrine active chemicals               
leading to higher BMI. 
The associations between BMI and environmental chemicals during the developmental           
period and childhood can be explored by prospective cohort studies looking at the exposure              
to environmental chemicals at birth and follow-up weight in the study participants; however,             
such studies have been limited. In a Belgian prospective cohort study(27) in the paediatric              
population, cord blood PCB (​congeners 118, 138, 153, 170, and 180) ​concentrations were             
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associated with increased follow-up BMI. Another study(28) showed that female foetuses           
with the highest transplacental PCB exposures were heavier for their heights than other girls              
(at age 11 years) who were not exposed, however, these associations were only significant in               
caucasian participants. However, other studies have shown either negative(29) or null           
associations between PCBs and BMI(30).  
Animal studies have also provided some evidence showing associations with obesity. A study             
by Ruzzin et al.(31) showed that male rats fed a high-fat diet of crude salmon oil (HFC)                 
containing high levels of persistent organic pollutants (POPs) or refined salmon oil (HFR)             
with significantly lower environmental chemicals levels showed increased abdominal obesity,          
and elevated levels of diacylglycerol, triacylglycerol, and total cholesterol in HFC rats            
compared with the HFR rats. HFC-fed rats developed insulin resistance, impaired lipid and             
glucose metabolism, and hepatosteatosis, confirming that chronic exposure to environmental          
chemicals severely impairs insulin sensitivity and contributes to abdominal obesity in male            
rats. 
A further issue relates to the impact of weight reduction upon the concentration and amount               
of dioxins in the body. There is the possibility that significant weight reduction could cause               
release of dioxin from adipose tissue depots, as the adipose tissue is lost, and that the                
concentrations in blood and adipose tissue of dioxin and other toxic lipophilic chemicals             
could increase if the dioxin remains in the body as adipose tissue is lost, potentially               
increasing the internal exposure level for toxicologically relevant tissues or receptors. There            
is evidence that weight loss is associated with an increase in PCBs and other highly lipophilic                
contaminants (Charlier et al. 2002; Chevrier et al. 2000; Kim et al. 2011; Pelletier et al.                
2002). However, the factors affecting the degree of increase in concentration, time profile of              
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changes after weight loss, and other mass balance issues have not been thoroughly assessed              
to date. The benefits of acute weight loss would be the primary finding but in the long term                  
when weight loss has plateaued then hypothetically the increased concentrations of these            
chemicals could have a detrimental effect, though longer studies are needed to confirm this. 
In this study, we also show that estimated concentrations of selected compounds increased in              
remaining fat depots following weight loss induced by bariatric surgery. Our findings are in              
agreement with an earlier study(16, 32) which showed that the serum PCB concentrations             
increased by approximately 50% following weight loss at six months follow-up. The data             
presented in our study are generally consistent with the hypothesis that compounds stored in              
fat are mobilized and redistributed into remaining fat tissue following weight loss. There are              
reports of association of polychlorinated biphenyls (PCBs), . In our study the degree of              
change in observed concentrations of environmental chemicals following weight loss differed           
substantially by the individual, even taking into account the different amount of weight loss              
and estimated losses in fat mass. However, for each individual, the degree of change in               
concentration was very similar across contaminants, suggesting a consistent quantity of           
release of compound and redeposition into the remaining fat mass regardless of the specific              
contaminant. This observation suggests that the differing degrees of change in concentration            
may be related to interindividual differences in the accuracy of the fat mass estimation              
procedure used. Other possible explanations include a ​individual differences in elimination           
half-lives​ and ​by a small sample size of the follow-up​.  
Our study had several limitations. Since this is a cross-sectional study, we are not able to                
establish a causal link between environmental chemicals and BMI. It is possible that the              
association of the environmental chemicals with BMI simply reflects the excess accumulation            
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of lipophilic environmental chemicals in participants with high BMI and high concentration            
of body lipids. Furthermore, in this cross-sectional study, we are not able to adjust for the                
timecourse of lifelong environmental exposure to these chemicals, which are important           
determinants of their concentration in the body. Also, the scope of this study was limited to                
investigating the association of these endocrine-active chemicals with BMI and changes in            
their concentration following bariatric surgery. Further studies are needed to investigate if the             
accumulation of these chemicals following bariatric surgery increases the likelihood of           
endocrine or hormonal dysfunction in the long term, though in the short term the beneficial               
effects of bariatric surgery would be more evident. All the participants from this study were               
recruited, from Hull and East Riding of Yorkshire, which is a highly stable population              
epidemiologically; therefore, different environmental exposure is less likely than in a mobile            
population, but a detailed migratory history was not obtained to confirm this. 
However, this study provides first paired liver and adipose tissue samples from adults for a                
range of environmental chemicals, including some with no previous human liver tissue data.             
We also show that if an environmental chemical is associated with BMI, this association is               
likely to be consistent across subcutaneous fat, visceral fat and in liver fat and likely is a                 
consequence of high correlation levels across these depots. We also provide evidence of             
environmental chemicals re-distribution following weight loss, which has implications for          
patients experiencing significant weight loss, whether following surgery, dietary restriction,          
or secondary to illness. In summary, we show an association between BMI and various              
polychlorinated biphenyls PCBs and structurally related polychlorinated dibenzo-p-dioxins        
dibenzofurans (PCDD/Fs) and increased subcutaneous fat concentrations following weight         
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loss. Further molecular, genetic and animal studies are needed to elucidate potential causal             
associations between these compounds and obesity..  
 
Data availability Statement 




Table 1: Demographic characteristics of the study population and chemicals measured in the             
study 
Age 55 (IQR =44-56) 
Gender %females 64% 
BMI 37 (IQR=27-37). 
Ortho-chlorinated biphenyls PCB 18, PCB 28, PCB 31,PCB 47, PCB 49.PCB 51, PCB 52, PCB 99, PCB 101, PCB 105, PCB 114, PCB 118
157, PCB 167, PCB 180, PCB 189 
Non-ortho-chlorinated 
biphenyls 
PCB 77, PCB 81,PCB 126, PCB 169 
 
PCDD/Fs 
2,3,7,8-TCDD; 1,2,3,7,8-PeCDD; 1,2,3,4,7,8-HxCDD; 1,2,3,6,7,8-HxCDD; 1,2,3,7,8,9-HxCDD; 1,2,3,4,6
2,3,4,7,8-PeCDF; 1,2,3,4,7,8-HxCDF ; 1,2,3,6,7,8-HxCDF ; 1,2,3,7,8,9-HxCDF ; 2,3,4,6,7,8-HxCDF ; 1
Polybrominated diphenyl 
ethers 
BDE 17,BDE 28,BDE 47,BDE 49,BDE 66,BDE 71,BDE 77,BDE 85,BDE 99,BDE 100,BDE 119,BDE 
Ortho and non-ortho 
brominated biphenyls 






Table 2: Association of BMI with log-10 transformed concentrations (ng/g lipid, except            
where indicated) of various chlorinated and brominated compounds, adjusted for age and            
gender. Results reported only for associations significant with P<0.007, the threshold for            
significance after Bonferroni correction in any of the three depots.  
und SCF Visceral Fat Liver 
Beta SE P-value Beta SE P-value Beta SE P-valu
13.28 4.16 2.23E-03 13.04 4.24 2.99E-03 12.39 4.11 3.81E
9 -11.56 6.4 0.07 -17.59 5.35 1.55E-03 -17.59 5.35 0.001
7 11.09  4.40  0.01 11.33 4.55 0.01 11.47 3.80 3.81E
8 10.5 3.27 2.13E-03 10.79 3.37 2.02E-03 3.98 3.36 0.24 
6 pg/g  13.90 2.89 1.13E-05 15.06 3.08 7.72E-06 10.53 3.36 2.90E
3 14.46 3.41 7.68E-05 13.58 3.39 1.50E-04 14.10 3.09 2.66E
8 15.76 3.30 1.15E-05 16.36 3.58 1.99E-05 14.10 3.09 2.66E
5 16.83 3.16 1.45E-06 16.65 3.48 8.80E-06 14.27 3.34 7.41E
-13.59 5.73 0.02 7.66 4.70 0.10 -15.87 5.56 6.53E
d pg/g lipid 13.01 4.45 4.93E-03 14.85 4.56 1.84E-03 2.90 4.98 056 
hxcdd, 
d 
14.25 3.82 4.39E-04 15.96 3.88 1.19E-04 1.88 2.86 051 
hxcdd, 
d 
10.70 3.61 4.40E-03 11.58 3.88 4.12E-03 NC NC NC 
8-hpcdd, 
s 
9.05 2.79 1.99E-03 9.47 3.10 3.32E-03 5.14 3.63 0.16 
 
NC: not calculated due to low detection frequencies. Association of BMI with             
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